These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 27076567)

  • 1. Transmission of Hepatitis B Core Antibody and Galactomannan Enzyme Immunoassay Positivity via Immunoglobulin Products: A Comprehensive Analysis.
    Ramsay I; Gorton RL; Patel M; Workman S; Symes A; Haque T; Irish D; Seneviratne SL; Burns SO; Wey E; Lowe DM
    Clin Infect Dis; 2016 Jul; 63(1):57-63. PubMed ID: 27076567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case report: passive transfer of hepatitis B antibodies from intravenous immunoglobulin.
    Parker S; Gil E; Hewitt P; Ward K; Reyal Y; Wilson S; Manson J
    BMC Infect Dis; 2014 Feb; 14():99. PubMed ID: 24559411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. False-positive Aspergillus galactomannan immunoassays associated with intravenous human immunoglobulin administration.
    Liu WD; Lin SW; Shih MC; Su CL; Wang YW; Lin SC; Lee YF; Huang HH; Chou WC; Wu UI; Chen YC; Chang SC
    Clin Microbiol Infect; 2020 Nov; 26(11):1555.e9-1555.e14. PubMed ID: 32061794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Case of Intravenous IVIg Interfering with Serological Test Results of HBV.
    Zhang D; Yu D
    Clin Lab; 2024 Jul; 70(7):. PubMed ID: 38965960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis.
    Koo YX; Tay M; Teh YE; Teng D; Tan DS; Tan IB; Tai DW; Quek R; Tao M; Lim ST
    Ann Hematol; 2011 Oct; 90(10):1219-23. PubMed ID: 21520001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of hepatitis B virus infection from hepatitis B core antibody-positive donor graft using hepatitis B immune globulin and lamivudine in living donor liver transplantation.
    Suehiro T; Shimada M; Kishikawa K; Shimura T; Soejima Y; Yoshizumi T; Hashimoto K; Mochida Y; Maehara Y; Kuwano H
    Liver Int; 2005 Dec; 25(6):1169-74. PubMed ID: 16343068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interpretation and management of positive anti-hepatitis B core antibody tests in immunocompromised pediatric patients.
    Kitt E; Hayes M; Cárdenas AM; Green AM
    Transpl Infect Dis; 2019 Jun; 21(3):e13074. PubMed ID: 30868720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection.
    Behzad-Behbahani A; Mafi-Nejad A; Tabei SZ; Lankarani KB; Torab A; Moaddeb A
    Indian J Med Res; 2006 Jan; 123(1):37-42. PubMed ID: 16567866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies against Hepatitis A and Hepatitis B Virus in Intravenous Immunoglobulin Products.
    Lee S; Kim HW; Kim KH
    J Korean Med Sci; 2016 Dec; 31(12):1937-1942. PubMed ID: 27822932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenge of hepatitis B testing following intravenous immunoglobulin therapy in patients with autoimmune skin diseases.
    Pruessmann JN; Langan EA; Rupp J; Marquardt J; Terheyden P; Zillikens D; Ludwig RJ; Boch K
    J Dermatol; 2022 Oct; 49(10):1049-1051. PubMed ID: 35726741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vertical transmission of hepatitis B virus (HBV) from mothers negative for HBV surface antigen and positive for antibody to HBV core antigen.
    Walz A; Wirth S; Hucke J; Gerner P
    J Infect Dis; 2009 Oct; 200(8):1227-31. PubMed ID: 19751152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of Hepatitis B Surface antibody levels in subjects receiving universal Hepatitis B vaccination in infancy in an area of hyperendemicity: correlation between radioimmunoassay and enzyme immunoassay.
    Wang CW; Wang LC; Chang MH; Ni YH; Chen HL; Hsu HY; Chen DS
    Clin Diagn Lab Immunol; 2005 Dec; 12(12):1442-7. PubMed ID: 16339069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The reliability of HBV core antibody in serological screening for hepatitis B virus.
    Ba Alawi F; Robertson PW; LePage AK; Jayamaha J; Baleriola C; Rawlinson WD
    Pathology; 2013 Aug; 45(5):501-5. PubMed ID: 23842045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen.
    Katz L; Strong DM; Tegtmeier G; Stramer S
    Transfusion; 2008 Nov; 48(11):2315-22. PubMed ID: 18647367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of hepatitis B core antibody-positive donor kidneys in hepatitis B surface antibody-positive and -negative recipients.
    Veroux M; Puliatti C; Gagliano M; Cappello D; Macarone M; Vizcarra D; Spataro M; Di Mare M; Ginevra N; Veroux P
    Transplant Proc; 2005; 37(6):2574-5. PubMed ID: 16182748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validity of the rapid strip assay test for detecting HBsAg in patients admitted to hospital in Uganda.
    Seremba E; Ocama P; Opio CK; Kagimu M; Yuan HJ; Attar N; Thomas DL; Lee WM
    J Med Virol; 2010 Aug; 82(8):1334-40. PubMed ID: 20572076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and analytical performance of the hepatitis B core related antigen immunoassay in hepatitis B patients.
    van Halewijn GJ; Geurtsvankessel CH; Klaasse J; van Oord GW; de Knegt RJ; van Campenhout MJ; Boonstra A; van der Eijk AA
    J Clin Virol; 2019 May; 114():1-5. PubMed ID: 30852396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Escape hepatitis B virus mutations in recipients of antibody to hepatitis B core antigen-positive liver grafts receiving hepatitis B immunoglobulins.
    Roche B; Roque-Afonso AM; Sebagh M; Delvart V; Duclos-Vallee JC; Castaing D; Samuel D
    Liver Transpl; 2010 Jul; 16(7):885-94. PubMed ID: 20583085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy.
    Lan JL; Chen YM; Hsieh TY; Chen YH; Hsieh CW; Chen DY; Yang SS
    Ann Rheum Dis; 2011 Oct; 70(10):1719-25. PubMed ID: 21719446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of quantitative assays for hepatitis B e antigen and IgM antibody to hepatitis B core antigen to monitor therapy in chronic hepatitis B.
    Hayashi PH; Beames MP; Kuhns MC; Hoofnagle JH; Di Bisceglie AM
    Am J Gastroenterol; 1996 Nov; 91(11):2323-8. PubMed ID: 8931411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.